177Lu-EB-LM3

N/A

Report date: 2025/11/24 11:49:24

Base Information

Drug Name177Lu-EB-LM3

Drug Alias Name177Lu-Evans blue(EB)-LM3177Lu-EB-LM3 1177Lu-EB-LM3 2177Lu-EB-LM3177Lu-EB-LM-3

ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Lutetium > 177LuRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionSomatostatin receptor antagonists

TargetsSomatostatin receptor

Therapy Area/IndicationsNeuroendocrine Tumors

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaDiscontinued

Originator CompaniesThe First Affiliated Hospital Of Xiamen University

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesThe First Affiliated Hospital Of Xiamen University

Active IndicationsN/A

Inactive IndicationsNeuroendocrine Tumors

Other Information

ATC CodeN/A